Courtney Miller

Courtney Miller is a Professor and Director of Academic Affairs at the University of Florida, specializing in neuroscience and translational drug discovery. Her work bridges molecular neurobiology with therapeutic development for neuropsychiatric disorders and cancers, operating through the dual-branch Miller Lab focused on memory mechanisms and myosin-targeted therapeutics.

Her educational background includes:

• Ph.D. in Neurobiology, University of California, Irvine (2005)
• Bachelor's of Science in Biopsychology, University of California, Santa Barbara (1999)
• Technology Ventures Certification, Collat School of Business (2007-2009)

Miller's research integrates in vivo memory studies with drug development, targeting non-muscle myosin II for substance use disorders, PTSD, and cancers like glioblastoma. Her lab's dual approach connects basic circuit mechanisms to clinical applications, resulting in co-founding Myosin Therapeutics and multiple high-impact publications in Cell and Nature Neuroscience.

Recent work shows accelerating translational focus, with 2025 publications on clinically viable myosin inhibitors and novel polydrug association models indicating strong momentum in oncology and addiction therapeutics.

Key honors include:

• PECASE (2016)
• Entrepreneur of the Year (BioFlorida, 2022)
• Election to American College of Neuropsychopharmacology (2020)
• NIDA Young Investigator Award (2005)

She directs multiple NIH-funded projects as Principal Investigator, including myosin inhibitor development for glioblastoma, neurodevelopmental disorder therapies, and REU programs training next-generation scientists at the chemistry-biology interface.